Literature DB >> 1430388

Perioral dermatitis in childhood.

S M Manders1, A W Lucky.   

Abstract

BACKGROUND: Although perioral dermatitis has been well described in young women, little has been reported about this condition in children.
OBJECTIVE: The purpose of this study was to define more clearly the features of perioral dermatitis in childhood.
METHODS: Fourteen children with perioral dermatitis were assessed for clinical features, therapeutic response, and possible etiologic factors.
RESULTS: Fourteen cases of perioral dermatitis were seen in 16 months, far exceeding the expected prevalence in childhood. Although the childhood variant shares many characteristics with the adult form, children often have periocular and perinasal lesions, as well as a higher relative incidence in boys. Mid- to high-potency topical corticosteroids were used in seven of the patients (50%) and likely contributed to the pathogenesis. All children responded rapidly to treatment.
CONCLUSION: Perioral dermatitis in childhood, often iatrogenic, is more common than previously reported.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430388     DOI: 10.1016/0190-9622(92)70238-b

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  "Tortured tube" sign.

Authors:  K P Fowler; D J Elpern
Journal:  West J Med       Date:  2001-06

2.  Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-08

3.  [Treatment-resistant granulomatous rosacea-like dermatitis in a 9-year-old girl].

Authors:  P Poblete-Gutiérrez; T Beermann; E I Grussendorf-Conen; J Frank
Journal:  Hautarzt       Date:  2004-10       Impact factor: 0.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.